B
grade
124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.
Evuzamitide · JAMA · 2026 · ObservationalTop journal
124I-evuzamitide PET/CT shows high sensitivity and specificity for diagnosing cardiac amyloidosis, but further studies are needed to confirm these findings.
Overall sensitivity was 94% (95% CI, 85%-98%; P < 0.001).